Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor expression when you look at the the hormone estrogen receptor-negative breast cancer

Bieche We, Parfait B, Tozlu S, Lidereau R, Vidaud Meters: Quantitation off androgen receptor gene phrase into the sporadic breast cancers by the real-go out RT-PCR: proof one MYC is an enthusiastic AR-managed gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/twenty two.nine.1521.

Bratthauer GL, Lininger RA, Kid YG, Tavassoli FA: Androgen and you will the hormone estrogen receptor mRNA position into the apocrine carcinomas. Diagn Mol Pathol. 2002, eleven (2): 113-118. 9606-200206000-00008.

Gatalica Z: Immunohistochemical study of apocrine nipple sores. Consistent more than-term regarding androgen receptor accompanied by the increased loss of estrogen and you will progesterone receptors in the apocrine metaplasia and you may apocrine carcinoma for the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.

Was J Clin Pathol

Soreide JA, Lea OA, Varhaug JE, Skarstein A great, Kvinnsland S: Androgen receptors within the operable cancer of the breast: relation to almost every other steroid hormonal receptors, correlations so you’re able to prognostic products and predictive worth to own aftereffect of adjuvant tamoxifen therapy. Eur J Surg Oncol. 1992, 18 (2): 112-118.

Bayer-Gather IB, Smoller B: Androgen receptors: good marker to improve susceptibility for determining cancer of the breast when you look at the facial skin metastasis away from unknown pri, thirteen (2): 119-122. /modpathol.3880021.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic pastime and you may clinical ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.

Pang ST, Flores-Morales A good, Skoog L, Chuan YC, Nordstedt Grams, Pousette A good: Control out of matrix metalloproteinase 13 expression from the androgen inside prostate cancer tumors. Oncol Representative. 2004, eleven (6): 1187-1192.

Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.

Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Investigations of your prognostic dependence on androgen receptor term within the metastatic cancer of the breast. Virchows Arc. 2006, 449 (1): 24-31. /s00428-006-0213-6.

Parker RL, Huntsman DG, Lesack DW, Cupples JB, Offer DR, Akbari Meters, Gilks CB: Research of interlaboratory variation on the immunohistochemical commitment away from estrogen receptor reputation playing with a cancer of the breast cells microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.

Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Study of matrix metalloproteinases and their inhibitors inside the breast cancer. Br J Cancer tumors. 2007, 96 (6): 903-911. /sj.bjc.6603666.

Narita D, Raica M, Suciu C, Cimpean A great, Anghel A good: Immunohistochemical phrase out-of androgen receptor and you will prostate-specific antigen from inside the cancer of the breast. Folia Histochem Cytobiol. 2006, forty two (3): 165-172.

Egeblad M, Werb Z: The characteristics towards the matrix metalloproteinases inside the cancers evolution. Nat Rev Cancer tumors. 2002, dos (3): 161-174. /nrc745.

Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–to the fundamental phase off cancers?. Cancers Cellphone. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.

Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira E, Martinez Air conditioning: New matrix metalloproteinase-nine handles the fresh new insulin-such as progress basis-brought about autocrine effect inside the DU-145 carcinoma structure. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..

Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel Yards: Release of an invasion promoter Elizabeth-cadherin fragment by the matrilysin and you can stromelysin-1. J Phone Sci. 2001, 114 (Pt 1): 111-118.

Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] phrase chooses to have tissue with reduced awareness so you’re able to apoptosis. Neoplasia. 2001, 3 (6): 459-468. /sj.neo.7900190.


Stetler-Stevenson WG: Matrix metalloproteinases during the angiogenesis: a moving address having healing intervention. J Clin Purchase. 1999, 103 (9): 1237-1241. /JCI6870.

Cornelius La, Nehring LC, Harding Elizabeth, Bolanowski M, Welgus HG, Kobayashi DK, Penetrate RA, Shapiro SD: Matrix metalloproteinases make angiostatin: effects with the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.

Jiang Y, Goldberg ID, Shi YE: State-of-the-art roles out-of structure inhibitors of metalloproteinases for the cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.

Leave a Comment

        Navigate your Future